5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Suzetrigine: new trials by email Literature Review of Suzetrigine trials Research Report on Suzetrigine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars LTG-001 High Dose, LTG-001 Mid Dose, LTG-001 Low Dose - Acute Pain, Postoperative | Phase 2 | Completed | Latigo Biotherapeutics | 250 | 2024-12-19 | 2026-05-22 |
| Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) VX-548, Placebo - Painful Lumbosacral Radiculopathy | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 218 | 2023-12-13 | 2025-10-01 |
| Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) Suzetrigine, Pregabalin, Placebo (matched to SUZ) - Diabetic Peripheral Neuropathy | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 194 | 2022-12-20 | 2025-07-01 |
| A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty VX-548, HB/APAP, Placebo (matched to VX-548) - Acute Pain | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 303 | 2021-08-30 | 2024-12-27 |
| A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy VX-548, HB/APAP, Placebo (matched to VX-548) - Acute Pain | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 274 | 2021-07-19 | 2025-06-25 |
Acute Pain (3) · Pain, Postoperative (1)
Vertex Pharmaceuticals Incorporated (4) · Latigo Biotherapeutics (1)
United States (5)